Resmed Inc’s filing revealed that its Director FARRELL PETER C unloaded Company’s shares for reported $0.46 million on Jan 02 ’25. In the deal valued at $230.99 per share,2,000 shares were sold. As a result of this transaction, FARRELL PETER C now holds 79,218 shares worth roughly $18.62 million.
Then, Rider Michael J sold 75 shares, generating $17,324 in total proceeds. Upon selling the shares at $230.99, the Global General Counsel now owns 9,038 shares.
Before that, FARRELL PETER C bought 2,000 shares. Resmed Inc shares valued at $500,000 were divested by the Director at a price of $250.00 per share.
Stifel initiated its Resmed Inc [RMD] rating to a Hold in a research note published on December 13, 2024; the price target was $250. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Wolfe Research also remained covering RMD and has decreased its forecast on September 18, 2024 with a “an Underperform” recommendation from previously “Peer perform” rating. Needham revised its rating on September 04, 2024. It rated RMD as “a Hold” which previously was an “a Buy”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock jump 1.48% to $235.09. Over the last five days, the stock has gained 0.82%. Resmed Inc shares have risen nearly 2.80% since the year began. Nevertheless, the stocks have risen 40.29% over the past one year. While a 52-week high of $260.49 was reached on 01/06/25, a 52-week low of $164.12 was recorded on 01/02/25. SMA at 50 days reached $241.12, while 200 days put it at $221.78.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 231.64, which if violated will result in even more drops to 228.20. On the upside, there is a resistance level at 237.89. A further resistance level may holdings at 240.70. The Relative Strength Index (RSI) on the 14-day chart is 48.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.84%. Stochastics %K at 34.24% indicates the stock is a holding.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2024-12-13, growing by 0.49 million shares to a total of 7.81 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 7.31 million shares. There was a rise of 6.33%, which implies that there is a positive sentiment for the stock.
